MAIA Biotechnology Inc (MAIA)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

MAIA Biotechnology Inc Stock (MAIA) Company Profile

MAIA Biotechnology Inc

Healthcare (1195)

Biotechnology (683)

312 416 8592

444 West Lake Street, Suite 1700, Chicago

Nächster Verdiensttermin

Neueste SEC-Einreichungen

MAIA's Discussions on Twitter

Vergleichen Sie MAIA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MAIA	2.1987	56.49M	0	-19.77M	-13.07M	-1.57
VRTX	449.07	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	747.78	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	587.28	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	247.71	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	106.50	24.89B	3.30B	-501.07M	1.03B	11.54

MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten

Finanzdaten der MAIA Biotechnology Inc-Aktie (MAIA)

MAIA Biotechnology Inc (MAIA)

MAIA Biotechnology Inc Stock (MAIA) Company Profile

Vergleichen Sie MAIA mit anderen Aktien

MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten

Diamond Equity Forecasts MAIA Biotechnology Q1 Earnings - Defense World

Analysts Set Expectations for MAIA Biotechnology Q1 Earnings - MarketBeat

MAIA Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

MAIA Biotechnology Inc (MAIA): A New Perspective - Stocks Register

MAIA Biotechnology Reveals Promising Phase 2 Trial Results - TipRanks

MAIAMAIA Biotechnology, Inc. Latest Stock News & Market Updates - StockTitan

MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement - BioSpace

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting - Yahoo Finance

Maia Biotechnology director Stan Smith buys shares worth $250,999 - Investing.com

Maia Biotechnology director Stan Smith buys shares worth $250,999 By Investing.com - Investing.com Canada

Insider Buying: MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Acquires 22,133 Shares of Stock - MarketBeat

Director Cristian Luput Acquires 22,133 Shares of MAIA Biotechno - GuruFocus.com

Director Ramiro Guerrero Acquires 88,534 Shares of MAIA Biotechn - GuruFocus.com

Maia Biotechnology director Steven Chaouki buys $55,553 in shares By Investing.com - Investing.com Australia

Maia Biotechnology director Steven Chaouki buys $55,553 in shares - Investing.com

Maia Biotechnology director Luput acquires shares worth $55,553 By Investing.com - Investing.com Nigeria

Maia Biotechnology director Luput acquires shares worth $55,553 - Investing.com

Cosmo Metals Secures $500,000 for Strategic Expansion - MSN

Antipa Minerals Expands Share Offering on ASX - MSN

WAM Alternative Assets Expands ASX Securities Offering - MSN

Argent BioPharma Issues New Shares Amidst Strategic Growth - MSN

MAIA Biotechnology Announces $2.44 Million Private Placement - Business Wire

MAIA Biotechnology (NYSEAMERICAN:MAIA) Stock Price Down 3.4%Here's What Happened - MarketBeat

MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Down 3.4% – Time to Sell? - Defense World

Alterity Therapeutics Prepares for 2024 Annual General Meeting - MSN

Li Bang International announces pricing of initial public offering - MSN

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics - BioSpace

MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Down 1.1% - MarketBeat

BioAge, BKV shares end their first trading day flat after earlier gains - MSN

Weight-loss drug developer BioAge Labs aims to raise $198M from U.S. IPO - MSN

Healthcare Stock Performance - Yahoo Finance

Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 7.8% - Defense World

Daiwa Securities Group Inc. Invests $82,000 in Haemonetics Co. (NYSE:HAE) - Defense World

Promising signs for MAIA’s telomere-targeting treatment - The Pharma Letter

Mayne Pharma Group (OTCMKTS:MAYNF) Shares Down 8% - Defense World

THIO Combo Yields Survival Benefit in Advanced NSCLC - AJMC.com Managed Markets Network

Bicara Leads Trio of US Biotech IPOs Raising $703 Million - Bloomberg

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CAE - PR Newswire

Summit Therapeutics jumps 4%, raises $235M - MSN

MAIA Biotechnology - The Pharma Letter

MAIA Biotechnology Reports Promising Interim Results in Lung Cancer Treatment Study - Vancity Buzz

MAIA Biotechnology Inc’s latest rating changes from various analysts - Knox Daily

MAIA reports survival benefit in advanced lung cancer trial - Investing.com

MAIA Biotech releases Phase II results for THIO - The Pharma Letter

MAIA reports survival benefit in advanced lung cancer trial By Investing.com - Investing.com Australia

MAIA Biotechnology Advances with Clinical Trials and Partnerships - TipRanks

MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - StockTitan

MAIA Biotechnology, Inc. to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference - Marketscreener.com

MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

MAIA Biotechnology (NYSEAMERICAN:MAIA) Stock Price Down 3.9% - MarketBeat

MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Down 3.9% - Defense World

Finanzdaten der MAIA Biotechnology Inc-Aktie (MAIA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie MAIA